These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 21607949)

  • 41. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.
    Masand RP; El-Mofty SK; Ma XJ; Luo Y; Flanagan JJ; Lewis JS
    Head Neck Pathol; 2011 Jun; 5(2):108-16. PubMed ID: 21305368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma.
    Maniakas A; Moubayed SP; Ayad T; Guertin L; Nguyen-Tan PF; Gologan O; Soulieres D; Christopoulos A
    Oral Oncol; 2014 Oct; 50(10):942-6. PubMed ID: 25096827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.
    Ragin CC; Taioli E; Weissfeld JL; White JS; Rossie KM; Modugno F; Gollin SM
    Br J Cancer; 2006 Nov; 95(10):1432-8. PubMed ID: 17003776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    Shaikh MH; Khan AI; Sadat A; Chowdhury AH; Jinnah SA; Gopalan V; Lam AK; Clarke DTW; McMillan NAJ; Johnson NW
    BMC Cancer; 2017 Nov; 17(1):792. PubMed ID: 29178862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus infection in Bowen disease: negative p53 expression, not p16(INK4a) overexpression, is correlated with human papillomavirus-associated Bowen disease.
    Murao K; Yoshioka R; Kubo Y
    J Dermatol; 2014 Oct; 41(10):878-84. PubMed ID: 25201325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
    Gupta S; Pandey P; Verma S; Verma A
    J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.
    Santos M; Landolfi S; Olivella A; Lloveras B; Klaustermeier J; Suárez H; Alòs L; Puig-Tintoré LM; Campo E; Ordi J
    Am J Surg Pathol; 2006 Nov; 30(11):1347-56. PubMed ID: 17063073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome.
    Sivars L; Näsman A; Tertipis N; Vlastos A; Ramqvist T; Dalianis T; Munck-Wikland E; Nordemar S
    Cancer Med; 2014 Apr; 3(2):376-84. PubMed ID: 24510528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of association between high-risk human papillomaviruses and oral squamous cell carcinoma in young Japanese patients.
    Rushatamukayanunt P; Morita K; Matsukawa S; Harada H; Shimamoto H; Tomioka H; Omura K
    Asian Pac J Cancer Prev; 2014; 15(10):4135-41. PubMed ID: 24935359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
    O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
    Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
    Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV.
    Klingenberg B; Hafkamp HC; Haesevoets A; Manni JJ; Slootweg PJ; Weissenborn SJ; Klussmann JP; Speel EJ
    Histopathology; 2010 Jun; 56(7):957-67. PubMed ID: 20636796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
    Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
    J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
    Dreyer JH; Hauck F; Barros MHM; Niedobitek G
    Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.